Dr. Kumaran Sathyamoorthy, MD, MPH
What this data tells you about Dr. Sathyamoorthy
Dr. Kumaran Sathyamoorthy is an urology physician in Houston, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Sathyamoorthy performed 6,676 Medicare services across 2,877 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sathyamoorthy received a total of $6,668 from 57 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sathyamoorthy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,666 | $2 | $10 |
| Office visit, established patient (20-29 min) | 1,662 | $65 | $136 |
| Urinalysis with microscopic exam | 1,404 | $3 | $14 |
| Bladder ultrasound after voiding | 894 | $8 | $100 |
| Diagnostic exam of bladder and urethra using an endoscope | 195 | $178 | $488 |
| New patient office visit (30-44 min) | 191 | $79 | $259 |
| Initial hospital admission, moderate complexity | 97 | $99 | $294 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 74 | $123 | $1,397 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 73 | $25 | $208 |
| Instillation of anti-cancer drug into bladder | 51 | $68 | $297 |
| Simple insertion of temporary bladder tube | 48 | $47 | $173 |
| Drug injection, under skin or into muscle | 45 | $11 | $79 |
| Injection, garamycin, gentamicin, up to 80 mg | 42 | $2 | $32 |
| Biopsy of prostate gland | 39 | $172 | $435 |
| Ultrasound scan of pelvic region through rectum | 32 | $105 | $305 |
| Ultrasonic guidance for needle placement | 29 | $46 | $195 |
| Office visit, established patient, complex (40-54 min) | 23 | $145 | $368 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 22 | $71 | $1,123 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 18 | $224 | $770 |
| Office visit, established patient (30-39 min) | 17 | $103 | $251 |
| Insertion of stent in ureter using an endoscope | 16 | $104 | $1,344 |
| Crushing of stone of ureter using an endoscope | 15 | $324 | $1,100 |
| Simple bladder irrigation and/or instillation | 12 | $41 | $288 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $529 | $2,551 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sathyamoorthy is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sathyamoorthy experienced with bcg treatment for bladder cancer?
Does Dr. Sathyamoorthy receive payments from pharmaceutical companies?
How do Dr. Sathyamoorthy's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology